烧伤患者外用含二醇抗菌药物相关高渗性代谢性酸中毒的系统综述
该系统综述检索MEDLINE、Embase、CENTRAL和Web of Science至2016年8月4日,纳入61项临床研究共10,282例烧伤患者和4种抗菌药物。9例患者(0.09%)在局部磺胺嘧啶银治疗期间出现高渗性代谢性酸中毒,血中分离出丙二醇可解释渗透压间隙升高。作者建议对使用含二醇外用抗菌药物的烧伤患者保持高度警惕并频繁监测渗透压间隙。
要点
- 烧伤患者使用含二醇外用抗菌药物时高渗性代谢性酸中毒罕见但可致命。
- 系统综述仅发现9例(0.09%)相关病例,均来自同一项专门探索该毒综合征的研究。
- 血中丙二醇可解释高渗性代谢性酸中毒患者的渗透压间隙升高。
核心结论
- 这是首个系统综述,发现含二醇外用抗菌药物相关高渗性代谢性酸中毒的 documented 病例极少,均来自同一项专门探索该毒综合征的研究。
- 对使用含二醇外用抗菌药物的烧伤患者保持高度怀疑并频繁监测渗透压间隙,可能有助于及时识别未来毒性。
研究设计与样本
- 系统综述,检索MEDLINE(Ovid)、Embase(Ovid)、CENTRAL(Ovid)和Web of Science(Thomson Reuters),从数据库建库至2016年8月4日。
- 纳入标准为临床烧伤患者研究,且至少一组接受含二醇外用治疗。
- 共纳入61项研究,涉及10,282例患者和4种不同抗菌药物。
主要发现
- 9例烧伤患者(0.09%)在局部磺胺嘧啶银治疗期间被记录出现高渗性代谢性酸中毒。
- 从这些患者血中分离出丙二醇,可解释其高渗透压间隙。
关键数值与推荐
- 9例烧伤患者(0.09%)在局部磺胺嘧啶银治疗期间出现高渗性代谢性酸中毒。
- 血中丙二醇可解释高渗透压间隙。
临床怎么用
- 对使用含二醇外用抗菌药物的烧伤患者,应保持高度怀疑并频繁监测渗透压间隙,以及时识别高渗性代谢性酸中毒。
局限性
- 仅发现极少数 documented 高渗性代谢性酸中毒病例,且全部来自同一项专门探索该毒综合征的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The well documented susceptibility of burn patients to acquired infections via damaged skin mandates application of antimicrobial agents. These agents are dissolved in various vehicles that augment skin absorption thus allowing greater efficacy. Polyethylene glycol (PEG) and Propylene glycol (PropG) are among the most commonly used vehicles, and both have been used in numerous medications and cosmetic products over the past few decades. Rarely, burn patients treated with agents containing these glycols present with a life threatening systemic toxidrome of hyperosmolar metabolic acidosis. We present a systematic review of outcomes in burn patients treated with similar agents. METHODS: Relevant studies were identified through systematic searches conducted in MEDLINE (Ovid), Embase (Ovid), CENTRAL (Ovid), and Web of Science (Thomson Reuters), from database inception to August 4th, 2016. All publications of clinical burn patient studies included at least one arm receiving a glycol based topical therapy. RESULTS: A total of 61 studies involving 10,282 patients and 4 different antimicrobial medications fulfilled the inclusion criteria. Nine burn patients (0.09%) were documented to present with hyperosmolar metabolic acidosis during topical silver sulfadiazine treatment. Propylene glycol isolated from their blood accounted for the high osmole gap. CONCLUSION: This first systematic review found very few cases of documented hyperosmolar metabolic acidosis, all within one study that had set to specifically explore this toxidrome. High index of suspicion with frequent osmolar gap monitoring may help identify future toxicities in a timely manner.
引用
- Leibson T, Davies P, Nickel C, et al. Hyperosmolar metabolic acidosis in burn patients exposed to glycol based topical antimicrobials-A systematic review. Burns. 2017. PMID: 28797572. doi:10.1016/j.burns.2017.06.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。